NCT00610883View on ClinicalTrials.gov

LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 1990

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

LSA4, Cyclophosphamide, Methotrexate, Daunomycin, L-asparaginase, BCNU

LSA4 intervention includes three phases: induction, consolidation and maintenance

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER